Novel concept of exosome-like liposomes for the treatment of Alzheimer's disease.
暂无分享,去创建一个
Marisa P. Sárria | J. Teixeira | R. Machado | A. Gomes | J. Sousa | C. Botelho | Ivo Lopes | Mário Fernandes | L. Magalhães | Marisa P. Sarriá
[1] Craig J. Neal,et al. Ceria Nanoparticles Decrease UVA-Induced Fibroblast Death Through Cell Redox Regulation Leading to Cell Survival, Migration and Proliferation , 2020, Frontiers in Bioengineering and Biotechnology.
[2] B. Chiang,et al. Modification of curcumin-loaded liposome with edible compounds to enhance ability of crossing blood brain barrier , 2020 .
[3] J. Teixeira,et al. Exosome-Like Nanoparticles: A New Type Of Nanocarrier. , 2020, Current medicinal chemistry.
[4] J. Homberg,et al. Crossing the Blood-Brain-Barrier: A bifunctional liposome for BDNF gene delivery – A Pilot Study , 2020, bioRxiv.
[5] Ayaz Anwar,et al. Gold-Conjugated Curcumin as a Novel Therapeutic Agent against Brain-Eating Amoebae , 2020, ACS omega.
[6] D. Sivaraman,et al. Potential antioxidant and anti-inflammatory action of Hypericum hookerianum extracts in a liposome system evaluated with zebrafish embryos , 2019, Journal of microencapsulation.
[7] A. Athanassiou,et al. Low-density polyethylene/curcumin melt extruded composites with enhanced water vapor barrier and antioxidant properties for active food packaging , 2019, Polymer.
[8] Liang Zhao,et al. Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT/GSK-3β pathway. , 2019, Nanoscale.
[9] Guijin Sun,et al. Exposure to DBP induces the toxicity in early development and adverse effects on cardiac development in zebrafish (Danio rerio). , 2019, Chemosphere.
[10] Isaac T S Li,et al. Challenges and opportunities in exosome research—Perspectives from biology, engineering, and cancer therapy , 2019, APL bioengineering.
[11] H. Ghazali,et al. Determination of cell viability using acridine orange/propidium iodide dual-spectrofluorometry assay , 2019, Cogent Food & Agriculture.
[12] N. Fullwood,et al. Liposome delivery systems for the treatment of Alzheimer’s disease , 2018, International journal of nanomedicine.
[13] A. Azadi,et al. Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation. , 2018, ACS chemical neuroscience.
[14] S. Saleem,et al. Zebrafish: an emerging real-time model system to study Alzheimer’s disease and neurospecific drug discovery , 2018, Cell Death Discovery.
[15] A. Llorente,et al. Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology , 2018, Journal of Lipid Research.
[16] Pablo Játiva,et al. Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases. , 2018, Nanomedicine.
[17] Denis Mottet,et al. Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape , 2018, Nanomaterials.
[18] Chenghua Gu,et al. Bridging barriers: a comparative look at the blood–brain barrier across organisms , 2018, Genes & development.
[19] Min Li,et al. Isolation of Exosome-Like Nanoparticles and Analysis of MicroRNAs Derived from Coconut Water Based on Small RNA High-Throughput Sequencing. , 2018, Journal of agricultural and food chemistry.
[20] Lijia Huang,et al. Exosome–Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs , 2018, Advanced science.
[21] R. Merkel,et al. Deciphering the Functional Composition of Fusogenic Liposomes , 2018, International journal of molecular sciences.
[22] R. Montesinos. Liposomal Drug Delivery to the Central Nervous System , 2017 .
[23] Ajazuddin,et al. Recent advancements in liposomes targeting strategies to cross blood‐brain barrier (BBB) for the treatment of Alzheimer's disease , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[24] H. Thu,et al. Exploring recent developments to improve antioxidant, anti-inflammatory and antimicrobial efficacy of curcumin: A review of new trends and future perspectives. , 2017, Materials science & engineering. C, Materials for biological applications.
[25] N. Sanlier,et al. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health , 2017, Critical reviews in food science and nutrition.
[26] S. Onteru,et al. Curcumin Encapsulated in Milk Exosomes Resists Human Digestion and Possesses Enhanced Intestinal Permeability in Vitro , 2017, Applied Biochemistry and Biotechnology.
[27] Eugenia Trushina,et al. Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease , 2017, Journal of Alzheimer's disease : JAD.
[28] Zhiqiang Gao,et al. Progress in Exosome Isolation Techniques , 2017, Theranostics.
[29] Mohamed Mahmud,et al. Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro , 2016, PloS one.
[30] M. Daczewska,et al. Zebrafish: A Model for the Study of Toxicants Affecting Muscle Development and Function , 2016, International journal of molecular sciences.
[31] Nur Adalier,et al. Vitamin E, Turmeric and Saffron in Treatment of Alzheimer’s Disease , 2016, Antioxidants.
[32] Huan Wang,et al. Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.
[33] K. Black,et al. Ocular indicators of Alzheimer’s: exploring disease in the retina , 2016, Acta Neuropathologica.
[34] H. T. Park,et al. RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer. , 2016, Biomaterials.
[35] Joshua L Hood. Post isolation modification of exosomes for nanomedicine applications. , 2016, Nanomedicine.
[36] M. Sökmen,et al. The antioxidant activity of some curcuminoids and chalcones , 2016, Inflammopharmacology.
[37] G. Golomb,et al. Reduced cytotoxicity and enhanced bioactivity of cationic antimicrobial peptides liposomes in cell cultures and 3D epidermis model against HSV. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[38] Laura M Ensign,et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. , 2016, Advanced drug delivery reviews.
[39] M. Chopp,et al. Exosomes as Tools to Suppress Primary Brain Tumor , 2016, Cellular and Molecular Neurobiology.
[40] Venkatareddy Nadithe,et al. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges , 2016, Acta pharmaceutica Sinica. B.
[41] Diwei Ho,et al. An Unexpected Transient Breakdown of the Blood Brain Barrier Triggers Passage of Large Intravenously Administered Nanoparticles , 2016, Scientific Reports.
[42] D. Merlin,et al. Plant derived edible nanoparticles as a new therapeutic approach against diseases , 2016, Tissue barriers.
[43] Myung Soo Kim,et al. Using exosomes, naturally-equipped nanocarriers, for drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[44] Steven M Jay,et al. Exogenous DNA Loading into Extracellular Vesicles via Electroporation is Size-Dependent and Enables Limited Gene Delivery. , 2015, Molecular pharmaceutics.
[45] V. Torchilin,et al. New Developments in Liposomal Drug Delivery. , 2015, Chemical reviews.
[46] S. Raimondo,et al. Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death , 2015 .
[47] Jiayi Zhao,et al. Ginsenoside Rg1 relieves tert-Butyl hydroperoxide-induced cell impairment in mouse microglial BV2 cells , 2015, Journal of Asian natural products research.
[48] Seyeon Park,et al. Neuroblastoma SH‐SY5Y cell‐derived exosomes stimulate dendrite‐like outgrowths and modify the differentiation of A375 melanoma cells , 2015, Cell biology international.
[49] A. Molinari,et al. Liposomes as nanomedical devices , 2015, International journal of nanomedicine.
[50] Tianzhi Yang,et al. Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio , 2015, Pharmaceutical Research.
[51] Hong Jiang,et al. Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles. , 2014, Molecular nutrition & food research.
[52] M. Baesso,et al. Curcumin-β-cyclodextrin inclusion complex: stability, solubility, characterisation by FT-IR, FT-Raman, X-ray diffraction and photoacoustic spectroscopy, and food application. , 2014, Food chemistry.
[53] Hong Jiang,et al. Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.
[54] M. Moses,et al. Inhibiting Metastatic Breast Cancer Cell Migration via the Synergy of Targeted, pH-triggered siRNA Delivery and Chemokine Axis Blockade , 2014, Molecular pharmaceutics.
[55] Jaesung Park,et al. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. , 2013, ACS nano.
[56] R. Welti,et al. Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[57] Jun Lu,et al. Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. , 2013, The Journal of allergy and clinical immunology.
[58] Stergios Pispas,et al. Incorporation of dimethoxycurcumin into charged liposomes and the formation kinetics of fractal aggregates of uncharged vectors , 2013, Journal of liposome research.
[59] Anton J. Enright,et al. The zebrafish reference genome sequence and its relationship to the human genome , 2013, Nature.
[60] M. Dea-Ayuela,et al. Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations. , 2013, International journal of pharmaceutics.
[61] A. Chow,et al. Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood–Brain Barrier Model and in Alzheimer’s Disease Tg2576 Mice , 2013, The AAPS Journal.
[62] Z. Gu,et al. Cholesterol Derivatives Based Charged Liposomes for Doxorubicin Delivery: Preparation, In Vitro and In Vivo Characterization , 2012, Theranostics.
[63] R. Joseph,et al. Water soluble complexes of curcumin with cyclodextrins: Characterization by FT-Raman spectroscopy , 2012 .
[64] Chia-Hung Chen,et al. A Lipo-PEG-PEI complex for encapsulating curcumin that enhances its antitumor effects on curcumin-sensitive and curcumin-resistance cells. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[65] D. Sharma,et al. Dementia – A Complete Literature Review on Various Mechanisms Involves in Pathogenesis and an Intracerebroventricular Streptozotocin Induced Alzheimer’s Disease , 2012 .
[66] Y. Li,et al. Curcumin protects SH-SY5Y cells from oxidative stress by up-regulating HO-1 via Phosphatidylinositol 3 Kinase/Akt/Nrf-2 and down-regulating HO-2 , 2012, Molecular Neurodegeneration.
[67] M. Masserini,et al. Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[68] A. Kinkhabwala,et al. A structural and functional ground plan for neurons in the hindbrain of zebrafish , 2011, Proceedings of the National Academy of Sciences.
[69] Dongmei Sun,et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[70] D. Casey,et al. Drugs for Alzheimer's disease: are they effective? , 2010, P & T : a peer-reviewed journal for formulary management.
[71] I. Barakat. Pierre , 2009 .
[72] Julie S. Jurenka. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. , 2009, Alternative medicine review : a journal of clinical therapeutic.
[73] I. Gülçin,et al. Antioxidant and radical scavenging properties of curcumin. , 2008, Chemico-biological interactions.
[74] Seema Singh. From Exotic Spice to Modern Drug? , 2007, Cell.
[75] Y. Wen,et al. Curcumin affects development of zebrafish embryo. , 2007, Biological & pharmaceutical bulletin.
[76] Fusheng Yang,et al. Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.
[77] K. Romøren,et al. Transfection efficiency and cytotoxicity of cationic liposomes in salmonid cell lines of hepatocyte and macrophage origin. , 2004, Biochimica et biophysica acta.
[78] Young-ho Kim,et al. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. , 2003, Carcinogenesis.
[79] N. Abbott,et al. Astrocyte–endothelial interactions and blood–brain barrier permeability * , 2002 .
[80] V. Prince,et al. Constructing the hindbrain: Insights from the zebrafish , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.
[81] P. Drapeau,et al. Time course of the development of motor behaviors in the zebrafish embryo. , 1998, Journal of neurobiology.
[82] F. Goñi,et al. Infrared studies of protein-induced perturbation of lipids in lipoproteins and membranes. , 1998, Chemistry and physics of lipids.
[83] S. Tatulian,et al. Infrared spectroscopy of proteins and peptides in lipid bilayers , 1997, Quarterly Reviews of Biophysics.
[84] C. Kimmel,et al. Stages of embryonic development of the zebrafish , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.
[85] R. Shankar,et al. Metal chelating ability and antioxidant properties of Curcumin-metal complexes - A DFT approach. , 2018, Journal of molecular graphics & modelling.
[86] M. Ferrari,et al. Exosomes as Reconfigurable Therapeutic Systems. , 2017, Trends in molecular medicine.
[87] Bo-hou Xia,et al. Curcumin , 2020, Medicine.
[88] P. Kewsuwan,et al. Development of curcumin liposome formulations using polyol dilution method , 2016 .
[89] S. S. Nogueira. Development of new DODAX:MO:DC-Chol nanoparticles containing BRAF-siRNA for colorectal cancer therapy , 2015 .
[90] A. Tiwari,et al. Nanocurcumin: a promising therapeutic advancement over native curcumin. , 2013, Critical reviews in therapeutic drug carrier systems.
[91] R. Salzer,et al. Quantification of brain lipids by FTIR spectroscopy and partial least squares regression. , 2009, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[92] Shrikant D. Mishra,et al. The effect of curcumin (turmeric) on Alzheimer's disease: An overview , 2008, Annals of Indian Academy of Neurology.
[93] J. Pincemail,et al. [Oxidative stress]. , 2007, Revue medicale de Liege.
[94] B. Teter,et al. Neuroprotective effects of curcumin. , 2007, Advances in experimental medicine and biology.
[95] G. Small,et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[96] P. Couvreur,et al. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. , 2000, International journal of antimicrobial agents.
[97] H. Jeghers,et al. Vitamin E. , 1959, The Practitioner.